Dr. Hussein Tawbi on Efficacy and Safety Results From the CheckMate 204 Melanoma Trial

Cancer Network spoke with Hussein Tawbi, MD, PhD, of MD Anderson Cancer Center, about the efficacy and safety of the combination of nivolumab plus ipilimumab in patients with symptomatic melanoma brain metastases.

Source: CancerNetwork - June 19, 2019 Category: Cancer & Oncology Authors: Hussein Abdul-Hassan Tawbi, MD, PhD Source Type: news